- 专利标题： Hepatitis C virus inhibitors
-
申请号： US13361541申请日： 2012-01-30
-
公开(公告)号： US08552047B2公开(公告)日： 2013-10-08
- 发明人: John A. Bender , Omar D. Lopez , Gan Wang , Makonen Belema , John F. Kadow
- 申请人： John A. Bender , Omar D. Lopez , Gan Wang , Makonen Belema , John F. Kadow
- 申请人地址： US NJ Princeton
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 当前专利权人地址： US NJ Princeton
- 代理商 Pamela A. Mingo
- 主分类号： A01N43/50
- IPC分类号： A01N43/50 ; A61K31/415 ; C07D403/02
摘要：
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
公开/授权文献
- US20130028859A1 Hepatitis C Virus Inhibitors 公开/授权日：2013-01-31